The use of yttrium in medical imaging and therapy: historical background and 
future perspectives

Tickner, BJ; Stasiuk, GJ; Duckett, SB; Angelovski, G

doi:10.1039/c9cs00840c

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

The use of yttrium in medical imaging and therapy: historical background and future perspectives

MPS-Authors

/persons/resource/persons83784

Angelovski, G
Research Group MR Neuroimaging Agents, Max Planck Institute for Biological Cybernetics, Max Planck Society;
Max Planck Institute for Biological Cybernetics, Max Planck Society;

External Resource

https://pubs.rsc.org/en/content/articlepdf/2020/cs/c9cs00840c
(出版社版)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Tickner, B., Stasiuk, G., Duckett, S., & Angelovski, G. (2020). The use of yttrium in medical imaging and therapy: historical background and future perspectives. Chemical Society Reviews, 49(17), 6169-6185. doi:10.1039/c9cs00840c.

引用: https://hdl.handle.net/21.11116/0000-0006-C2DE-5

要旨

Yttrium is a chemically versatile rare earth element that finds use in a range of applications including lasers and superconductors. In medicine, yttrium-based materials are used in medical lasers and biomedical implants. This is extended through the array of available yttrium isotopes to enable roles for 90Y complexes as radiopharmaceuticals and 86Y tracers for positron emission tomography (PET) imaging. The naturally abundant isotope 89Y is proving to be suitable for nuclear magnetic resonance investigations, where initial reports in the emerging field of hyperpolarised magnetic resonance imaging (MRI) are promising. In this review we explore the coordination and radiochemical properties of yttrium, and its role in drugs for radiotherapy, PET imaging agents and perspectives for applications in hyperpolarised MRI.